Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jonas

Showing results (131-140 of 314) with videos related to

Pageof 32
Sort By:
Cancer Research|February 24, 1999
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancersJ Serth, F Panitz, U Paeslack, et al.
Urology|March 15, 2001
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladderP Van Kerrebroeck, K Kreder, U Jonas, et al.
World Journal of Urology|August 5, 2000
The history of endocrine therapy of benign and malignant diseases of the prostateS Machtens, D Schultheiss, M Kuczyk, et al.
European Urology|July 21, 2001
Male lower urinary tract symptoms and related health care seeking in GermanyR R Berges, L Pientka, K Höfner, et al.
World Journal of Urology|January 1, 1994
Effects of magnesium citrate and phytin on reducing urinary calcium excretion in ratsN Wu, W F Thon, H Krah, et al.
The American Journal of Pathology|April 7, 2000
Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sectionsJ Serth, M A Kuczyk, U Paeslack, et al.
Der Urologe. Ausg. A|January 1, 1995
[Thermotherapy of benign prostatic hyperplasia]K Höfner, H Krah, H K Tan, et al.
Biochemical and Biophysical Research Communications|May 14, 1993
Identification of a fourth angiotensin AT1 receptor subtype in ratA W Hahn, U Jonas, F R Buehler, et al.
FEBS Letters|June 27, 1994
Activation of human peripheral monocytes by angiotensin IIA W Hahn, U Jonas, F R Bühler, et al.
Investigative Urology|March 1, 1976
Urodynamic evaluation of a chronically implanted bladder pacemakerL W Jones, U Jonas, E A Tanagho, et al.
Pageof 32

Showing results (131-140 of 314) with videos related to

Sort By:
Pageof 32
Cancer Research|February 24, 1999
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancersJ Serth, F Panitz, U Paeslack, et al.
Urology|March 15, 2001
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladderP Van Kerrebroeck, K Kreder, U Jonas, et al.
World Journal of Urology|August 5, 2000
The history of endocrine therapy of benign and malignant diseases of the prostateS Machtens, D Schultheiss, M Kuczyk, et al.
European Urology|July 21, 2001
Male lower urinary tract symptoms and related health care seeking in GermanyR R Berges, L Pientka, K Höfner, et al.
World Journal of Urology|January 1, 1994
Effects of magnesium citrate and phytin on reducing urinary calcium excretion in ratsN Wu, W F Thon, H Krah, et al.
The American Journal of Pathology|April 7, 2000
Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sectionsJ Serth, M A Kuczyk, U Paeslack, et al.
Der Urologe. Ausg. A|January 1, 1995
[Thermotherapy of benign prostatic hyperplasia]K Höfner, H Krah, H K Tan, et al.
Biochemical and Biophysical Research Communications|May 14, 1993
Identification of a fourth angiotensin AT1 receptor subtype in ratA W Hahn, U Jonas, F R Buehler, et al.
FEBS Letters|June 27, 1994
Activation of human peripheral monocytes by angiotensin IIA W Hahn, U Jonas, F R Bühler, et al.
Investigative Urology|March 1, 1976
Urodynamic evaluation of a chronically implanted bladder pacemakerL W Jones, U Jonas, E A Tanagho, et al.
Pageof 32